MustGrow Biologics Balance Sheet Health
Financial Health criteria checks 6/6
MustGrow Biologics has a total shareholder equity of CA$3.7M and total debt of CA$518.0K, which brings its debt-to-equity ratio to 13.8%. Its total assets and total liabilities are CA$4.9M and CA$1.1M respectively. MustGrow Biologics's EBIT is CA$96.7K making its interest coverage ratio -0.4. It has cash and short-term investments of CA$4.7M.
Key information
13.8%
Debt to equity ratio
CA$517.99k
Debt
| Interest coverage ratio | -0.4x |
| Cash | CA$4.67m |
| Equity | CA$3.75m |
| Total liabilities | CA$1.15m |
| Total assets | CA$4.89m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MGRO's short term assets (CA$4.9M) exceed its short term liabilities (CA$1.0M).
Long Term Liabilities: MGRO's short term assets (CA$4.9M) exceed its long term liabilities (CA$140.9K).
Debt to Equity History and Analysis
Debt Level: MGRO has more cash than its total debt.
Reducing Debt: MGRO's debt to equity ratio has reduced from 768% to 13.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MGRO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MGRO has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 10.2% each year